Black patients with Alzheimer’s disease more likely to have mixed pathology
Source: US National Institute on Aging, Alzheimer’s Disease Education and Referral Center
The neuropathology of Alzheimer’s disease (AD) has been studied almost exclusively in white people, despite the fact that black people may be more likely to develop the disease. To begin to correct this imbalance, an autopsy study reports neuropathological findings from 41 black patients and 81 case-matched white patients with AD.
The findings suggest that black AD patients are less likely than their white counterparts to have Alzheimer pathology alone (19.5% versus 42.0%), and more likely to have Alzheimer pathology mixed with other pathology, such as Lewy bodies and infarcts (70.7% versus 50.6%). Black patients also had more severe arteriolar sclerosis and atherosclerosis.
The authors of the study, published in Neurology (online, 15 July 2015), emphasise the need for specific AD prevention and treatment strategies in African-Americans.
Citation: Electronicjuice DOI: 10.1211/PJ.2015.20069013
Recommended from Pharmaceutical Press
All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.£27.00
Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.£38.00
An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.£54.00
Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.£38.00
An introduction to the treatment of disease using biological medicines derived from living plant and animal tissues.£33.00